Development of a Multidimensional Assessment Tool for the Evaluation of Holistic Quality of Life in Parkinson's Disease.

Parkinson’s disease assessment tool health-related quality of life holistic personalized care prognostication

Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2022
Historique:
pubmed: 5 10 2021
medline: 28 4 2022
entrez: 4 10 2021
Statut: ppublish

Résumé

Parkinsonian syndromes are heterogeneous chronic neurodegenerative disorders associated with both motor and non-motor symptoms. The symptoms have major psychosocial effects on the quality of life of patients and can be a burden for caregivers. So far, several questionnaires have been developed to assess quality of life in Parkinsonism, but none of these include the positive sides on well-being such as personal and social resilience factors. The aim of this study is to develop a digital framework for a longitudinal assessment of quality of life during the progression of Parkinson's disease. The CHAPO model (Challenges and Potentials) has been established in a vast study by Wagner et al. to assess the quality of life of older people. This model includes environmental and individual factors, life chances, and life results, such as individual life evaluation, from a subjective as well as an objective point of view. Therefore, it has been adapted in several development steps to include the specific aspects that affect quality of life in Parkinsonian syndromes. The development process included 6 steps: definition, refinement, operationalization, piloting/debriefing, adjustment, and integration. The development of the CHAPO-PD model has been completed and it represents the first main result of this study. By taking a holistic understanding of quality of life into account, we expect to detect previously unrecognized factors, which correlate to the subjective well-being of Parkinson's disease patients, and aim to use these findings to improve the health care structures for patients with Parkinson's disease and related disorders.

Sections du résumé

BACKGROUND
Parkinsonian syndromes are heterogeneous chronic neurodegenerative disorders associated with both motor and non-motor symptoms. The symptoms have major psychosocial effects on the quality of life of patients and can be a burden for caregivers. So far, several questionnaires have been developed to assess quality of life in Parkinsonism, but none of these include the positive sides on well-being such as personal and social resilience factors.
OBJECTIVE
The aim of this study is to develop a digital framework for a longitudinal assessment of quality of life during the progression of Parkinson's disease.
METHODS
The CHAPO model (Challenges and Potentials) has been established in a vast study by Wagner et al. to assess the quality of life of older people. This model includes environmental and individual factors, life chances, and life results, such as individual life evaluation, from a subjective as well as an objective point of view. Therefore, it has been adapted in several development steps to include the specific aspects that affect quality of life in Parkinsonian syndromes. The development process included 6 steps: definition, refinement, operationalization, piloting/debriefing, adjustment, and integration.
RESULTS
The development of the CHAPO-PD model has been completed and it represents the first main result of this study.
CONCLUSION
By taking a holistic understanding of quality of life into account, we expect to detect previously unrecognized factors, which correlate to the subjective well-being of Parkinson's disease patients, and aim to use these findings to improve the health care structures for patients with Parkinson's disease and related disorders.

Identifiants

pubmed: 34602498
pii: JPD202391
doi: 10.3233/JPD-202391
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-370

Auteurs

Franziska Thieken (F)

Department of Neurology, University Hospital of Marburg, Marburg, Germany.

Lars Timmermann (L)

Department of Neurology, University Hospital of Marburg, Marburg, Germany.

Keywan Sohrabi (K)

Faculty of Health Sciences, University of Applied Sciences - THM, Giessen, Germany.

Christiane Woopen (C)

Ceres - Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health, University of Cologne, Cologne, Germany.
Medical Faculty, Research Unit Ethics, University of Cologne, University of Cologne, Cologne, Germany.

Björn Schmitz-Luhn (B)

Ceres - Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health, University of Cologne, Cologne, Germany.

Anna Janhsen (A)

a.r.t.e.s. Graduate School for the Humanities. University of Cologne, Cologne, Germany.

Carsten Eggers (C)

Department of Neurology, University Hospital of Marburg, Marburg, Germany.
CMBB - Center for Mind, Brain and Behavior of the Universities Giessen and Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH